William Ho - Net Worth and Insider Trading

William Ho Net Worth

The estimated net worth of William Ho is at least $122,113 dollars as of 2024-05-02. William Ho is the Chief Medical Officer of RAPT Therapeutics Inc and owns about 15,020 shares of RAPT Therapeutics Inc (RAPT) stock worth over $122,113. Details can be seen in William Ho's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William Ho has not made any transactions after 2023-12-21 and currently still holds the listed stock(s).

Transaction Summary of William Ho

William Ho Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William Ho owns 1 companies in total, including RAPT Therapeutics Inc (RAPT) .

Click here to see the complete history of William Ho’s form 4 insider trades.

Insider Ownership Summary of William Ho

Ticker	Comapny	Transaction Date	Type of Owner
RAPT	RAPT Therapeutics Inc	2023-12-21	Chief Medical Officer

William Ho Latest Holdings Summary

William Ho currently owns a total of 1 stock. William Ho owns 15,020 shares of RAPT Therapeutics Inc (RAPT) as of December 21, 2023, with a value of $122,113.

Latest Holdings of William Ho

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
RAPT	RAPT Therapeutics Inc	2023-12-21	15,020	8.13	122,113

Holding Weightings of William Ho

William Ho Form 4 Trading Tracker

According to the SEC Form 4 filings, William Ho has made a total of 51 transactions in RAPT Therapeutics Inc (RAPT) over the past 5 years, including 0 buys and 51 sells. The most-recent trade in RAPT Therapeutics Inc is the sale of 2,500 shares on December 21, 2023, which brought William Ho around $54,200.

Insider Trading History of William Ho

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William Ho Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

William Ho Ownership Network

Ownership Network List of William Ho

No Data

Ownership Network Relation of William Ho

William Ho Owned Company Details

What does RAPT Therapeutics Inc do?

Who are the key executives at RAPT Therapeutics Inc?

William Ho is the Chief Medical Officer of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , 10 percent owner Column Group Ii, Lp , and 10 percent owner Tcg Iv Gp, Llc .

RAPT Therapeutics Inc (RAPT) Insider Trades Summary

Over the past 18 months, William Ho made 10 insider transaction in RAPT Therapeutics Inc (RAPT) with a net sale of 39,000. Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 1,640 shares made by Dirk G. Brockstedt , a net purchase of 5,000 shares made by Wendye Robbins ,

In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,640 shares of RAPT Therapeutics Inc (RAPT) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 35,640 shares.

RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

RAPT Therapeutics Inc Insider Transactions

No Available Data

William Ho Mailing Address

Above is the net worth, insider trading, and ownership report for William Ho. You might contact William Ho via mailing address: 561 Eccles Avenue, South San Francisco Ca 94080.

Discussions on William Ho

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.